Melanotan is a prescription therapy used for skin pigmentation support.

Patients seeking support for skin pigmentation support may qualify after evaluation by a licensed provider.

Yes. Melanotan is a compounded prescription medication requiring a valid prescription from a licensed healthcare provider. A telehealth consultation and medical intake are required before dispensing to confirm suitability, evaluate skin type and pigmentation history, and screen for all relevant contraindications.

Melanotan is generally well tolerated at prescribed doses. Common side effects may include nausea, facial flushing, and mild fatigue — particularly during initial dosing as the body adjusts to melanocyte stimulation. Spontaneous erections have been reported in male patients due to central receptor activity. Injection site reactions may occur. Skin darkening beyond the intended effect or uneven pigmentation has been reported in some patients. Any change in the appearance of a pre-existing mole or pigmented lesion during treatment should be evaluated by a dermatologist promptly.

Melanotan is not appropriate for patients with a personal or family history of melanoma or dysplastic nevi without explicit dermatologist clearance. Patients with pigmentation disorders, photosensitivity conditions, or hormone-sensitive cancers should discuss use with their provider before initiating. It is not appropriate for patients who are pregnant or breastfeeding, those under 18, or those with significant hepatic or renal impairment. Patients with a history of cardiovascular conditions should disclose this, as Melanotan can influence blood pressure and heart rate.

Formal drug interaction studies have not been conducted. Patients on medications that affect blood pressure, heart rate, or sexual function should discuss concomitant use with their provider, as Melanotan may have additive or interactive effects in these areas. Concurrent use of photosensitizing medications may amplify UV sensitivity during treatment, requiring additional sun protection measures. Always provide a complete medication list before beginning treatment.

Patients with a personal or family history of melanoma or those with numerous or atypical moles must not use Melanotan without dermatologist evaluation and explicit clearance. Those with hormone-sensitive conditions, cardiovascular disease, or significant renal or hepatic impairment require individualized provider assessment. All eligible patients should have a thorough skin evaluation before starting and perform regular self-examination of pigmented lesions throughout treatment.